ArticleBMC health services research2014
Cost-outcome description of clinical pharmacist interventions in a university teaching hospital.
Article in BMC health services research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Potential Direct Costs of Adverse Drug Events and Possible Cost Savings Achievable by their Prevention in Tuscany, Italy: A Model-Based Analysis.Drug safety · 2019Pooled it
- Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial.BMC geriatrics · 2018Trial
- Key performance indicators for hospital clinical pharmacy services: results of a global Delphi study.International journal of clinical pharmacy · 2026Article
- Economic impact of medication management by clinical pharmacists in a urology department.Central European journal of urology · 2026Article
- The Cost of Resource Use Relative to the Development of the Antimicrobial Stewardship Program in a Tertiary Cancer Setting in Qatar.Antibiotics (Basel, Switzerland) · 2025Article
- Nutrition support therapy prescribing practices in hospice and palliative care units: a retrospective cohort study investigating physician prescribing practices and roles of pharmacists at a tertiary cancer center.Journal of the Egyptian National Cancer Institute · 2025Article
- Improving the provision of clinical pharmacy services in low- and middle-income countries: a qualitative study in tertiary health facilities in Tanzania.BMJ public health · 2025Article
- Cost avoidance of pharmacist-led deprescribing using STOPPFrail for older adults in nursing homes.International journal of clinical pharmacy · 2024Article
- Medication reviews by emergency department pharmacists in patients hospitalised for an adverse drug event: a cost study.BMC health services research · 2024Article
- [INTERPOLAR-prospective, interventional studies as part of the Medical Informatics Initiative to improve medication therapy safety in healthcare].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2024Article
- Financial impact of medication reviews by clinical pharmacists to reduce in-hospital adverse drug events: a return-on-investment analysis.International journal of clinical pharmacy · 2024Article
- Clinical pharmacists' interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis.Journal of pharmaceutical policy and practice · 2024Article
- The cost associated with the development of the antimicrobial stewardship program in the adult general medicine setting in Qatar.Journal of pharmaceutical policy and practice · 2024Article
- Cardiac intensive care unit: where we are in 2023.Frontiers in cardiovascular medicine · 2023Review
- Medical students' and health professionals' knowledge regarding acute kidney injury: a cross-sectional study in the city of São Paulo, Brazil.Renal failure · 2022Article
- Cost benefit analysis of clinical pharmacist interventions in medical intensive care unit in Palestine medical complex: Prospective interventional study.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022Article
- Directions of Changes in the Profession of Hospital Pharmacist in Poland.International journal of environmental research and public health · 2022Article
- The Impacts of Clinical Pharmacists' Interventions on Clinical Significance and Cost Avoidance in a Tertiary Care University Hospital in Oman: A Retrospective Analysis.Pharmacy (Basel, Switzerland) · 2022Article
- Article
- Primary palliative care recommendations for critical care clinicians.Journal of intensive care · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPharmacist interventions are one of the pivotal parts of a clinical pharmacy service within a hospital. This study estimates the cost avoidance generated by pharmacist interventions due to the prevention of adverse drug events (ADE). The types of interventions identified are also analysed.
methodsInterventions recorded by a team of hospital pharmacists over a one year time period were included in the study. Interventions were assigned a rating score, determined by the probability that an ADE would have occurred in the absence of an intervention. These scores were then used to calculate cost avoidance. Net cost benefit and cost benefit ratio were the primary outcomes. Categories of interventions were also analysed.
resultsA total cost avoidance of €708,221 was generated. Input costs were calculated at €81,942. This resulted in a net cost benefit of €626,279 and a cost benefit ratio of 8.64: 1. The most common type of intervention was the identification of medication omissions, followed by dosage adjustments and requests to review therapies.
conclusionThis study provides further evidence that pharmacist interventions provide substantial cost avoidance to the healthcare payer. There is a serious issue of patient's regular medication being omitted on transfer to an inpatient setting in Irish hospitals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.